Delivery Order SPE2DB25D3012-SPE2DB26FWVSQ
- Not listed
- The Defense Logistics Agency awarded a $1,790.80 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, with completion targeted for October 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the contractor's pharmaceutical supply services to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $17,908 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,079.06 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract issued on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 21, 2025, for the supply of HYPERRAB 300 Unit/ML Vial pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $3,465.10 with an ultimate completion date of October 10, 2025, and was awarded without set-aside designations through competitive procedures. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.04 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of HYPERRAB 300 Unit/mL Vial 5mL, with a ceiling value of $1,733.74 and an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania. The order represents a child contract under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for HYPERRAB 300 Unit/ml Vial pharmaceutical products with a ceiling value of $2,079.06 and a firm fixed price structure. The contract is set for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $14,053.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML) on May 30, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation and will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,954.00 for 300 units per milliliter of HYPERRAB in 5ML vials under a firm fixed price contract. This competitively awarded delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing full and open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for HYPERRAB 300 Unit/ML vial medication with a ceiling value of $1,386.04. This is a firm fixed price, non-set-aside competitive award with a completion date of September 8, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVSQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HYPERRAB 300 Unit/ML Vials, with a ceiling value of $4,158.12 and an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen Drug Corp serves multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, providing flexibility in fulfilling federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 11/3/25 |